62% of chordomas express the High Molecular Weight Melanoma Associated Antigen, also known as Chondroitin sulfate proteoglycan 4 (CSPG4) which has been the target of immune therapy.
sˈɪksti tˈuː pɚsˈɛnt ʌv kɔːɹdˈoʊməz ɛkspɹˈɛs ðə hˈaɪ məlˈɛkjʊlɚ wˈeɪt mˌɛlɐnˈoʊmə ɐsˈoʊsɪˌeɪɾᵻd ˈæntɪdʒˌɛn, ˈɔːlsoʊ nˈoʊn æz kˈɑːndɹɔɪtˌɪn sˈʌlfeɪt pɹˈoʊɾəɡlˌɪkən fˈoːɹ sˌiːˌɛspˌiːdʒˈiː fˈoːɹ wˌɪtʃ hˈæzbiːn ðə tˈɑːɹɡɪt ʌv ɪmjˈuːn θˈɛɹəpi.